Sort
27,075 grants matching “cholesterol”
CORE--Clinical Core
$338,360Kitt F Petersen · Yale University · P01 · FY2007 · DK
Mapping the Evolution of a Novel Enzyme by Experiment and Computation
$338,295Yi Tang · University Of California Los Angeles · R01 · FY2015 · GM
Mapping the Evolution of a Novel Enzyme by Experiment and Computation
$338,295Yi Tang · University Of California Los Angeles · R01 · FY2012 · GM
Mapping the Evolution of a Novel Enzyme by Experiment and Computation
$338,295Yi Tang · University Of California Los Angeles · R01 · FY2014 · GM
Exploiting Caveolae-Dependent Albumin Endocytosis to Optimize Therapy in Pancreatic Cancer
$338,263Terence Marques Williams · Ohio State University · R01 · FY2020 · CA
Cholesterol Sensitivity and Mechanisms of MSC Responses to 3D Substrate Rigidity
$338,262Rocky S. Tuan · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · EB
Sparstolonin B as an anti-atherogenic agent
$338,254Daping Fan · University Of South Carolina At Columbia · R01 · FY2014 · HL
CELL MUTANTS DEFECTIVE IN CHOLESTEROL ESTER FORAMTION
$338,228Dartmouth College · R37 · FY2000 · HL
Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus
$338,213Andrew W. Tai · University Of Michigan At Ann Arbor · R01 · FY2017 · DK
Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus
$338,213Andrew W. Tai · University Of Michigan At Ann Arbor · R01 · FY2014 · DK
Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus
$338,213Andrew W. Tai · University Of Michigan At Ann Arbor · R01 · FY2016 · DK
Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus
$338,213Andrew W. Tai · University Of Michigan At Ann Arbor · R01 · FY2015 · DK
Clinical Investigations of Smith-Lemli-Opitz Syndrome
$338,195Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Clinical Investigations of Niemann-Pick Disease, type C
$338,195Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
Molecular Basis of High Density Lipoprotein Deficiency
$338,168Ernst John Schaefer · Tufts University Boston · R01 · FY2008 · HL
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration
$338,154Goldis Malek · Duke University · R01 · FY2015 · EY
Mechanotransduction Pathways of Endothelial Barrier Regulation
$338,148Konstantin G Birukov · University Of Chicago · P01 · FY2008 · HL
High Density Lipoprotein Metabolism Influence of Extracellular Phospholipases
$338,147Daniel James Rader · University Of Pennsylvania · R01 · FY2008 · HL
High Density Lipoprotein Metabolism Influence of Extracellular Phospholipases
$338,147Daniel James Rader · University Of Pennsylvania · R01 · FY2007 · HL
Lipoxygenases in Atherosclerosis
$338,145Garret A Fitzgerald · University Of Pennsylvania · R01 · FY2007 · HL
Project 3
$338,116John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2025 · CA
Statistical Genetics of Outcomes and Drug Response in Patients with Type 2 Diabetes.
$338,087Alison Motsinger-Reif · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
CVD Risk and Outcome Heterogeneity in Older Adults with Diabetes
$338,084Caroline S Blaum · New York University School Of Medicine · R01 · FY2017 · AG
Cholesterol Sensitivity and Mechanisms of MSC Responses to 3D Substrate Rigidity
$338,067Rocky S. Tuan · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · EB
Macrophage Cell-Surface Proteolysis and Inflammation
$338,064Elaine Raines · University Of Washington · P01 · FY2010 · HL